Willie Frederick Mollentze
University of the Free State
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Willie Frederick Mollentze.
Diabetic Medicine | 2000
Naomi S. Levitt; Nigel Unwin; Debbie Bradshaw; Henry M Kitange; Jean Claude Mbanya; Willie Frederick Mollentze; Mahomed A.K. Omar; Ayesha A. Motala; Gina Joubert; Gabriel Masuki; Harun Machibya
Aims To examine the implications for epidemiological studies of the American Diabetes Association (ADA) recommendation that the fasting blood glucose at a lowered level becomes the main diagnostic test for diabetes on cross‐sectional‐based data from sub‐Saharan Africa.
BMC Medicine | 2013
Thomas A. Gaziano; Ankur Pandya; Krisela Steyn; Naomi S. Levitt; Willie Frederick Mollentze; Gina Joubert; Corinna M. Walsh; Ayesha A. Motala; Annamarie Kruger; Aletta E. Schutte; Datshana P. Naidoo; Dorcas Rosaley Prakaschandra; Ria Laubscher
BackgroundAll rigorous primary cardiovascular disease (CVD) prevention guidelines recommend absolute CVD risk scores to identify high- and low-risk patients, but laboratory testing can be impractical in low- and middle-income countries. The purpose of this study was to compare the ranking performance of a simple, non-laboratory-based risk score to laboratory-based scores in various South African populations.MethodsWe calculated and compared 10-year CVD (or coronary heart disease (CHD)) risk for 14,772 adults from thirteen cross-sectional South African populations (data collected from 1987 to 2009). Risk characterization performance for the non-laboratory-based score was assessed by comparing rankings of risk with six laboratory-based scores (three versions of Framingham risk, SCORE for high- and low-risk countries, and CUORE) using Spearman rank correlation and percent of population equivalently characterized as ‘high’ or ‘low’ risk. Total 10-year non-laboratory-based risk of CVD death was also calculated for a representative cross-section from the 1998 South African Demographic Health Survey (DHS, n = 9,379) to estimate the national burden of CVD mortality risk.ResultsSpearman correlation coefficients for the non-laboratory-based score with the laboratory-based scores ranged from 0.88 to 0.986. Using conventional thresholds for CVD risk (10% to 20% 10-year CVD risk), 90% to 92% of men and 94% to 97% of women were equivalently characterized as ‘high’ or ‘low’ risk using the non-laboratory-based and Framingham (2008) CVD risk score. These results were robust across the six risk scores evaluated and the thirteen cross-sectional datasets, with few exceptions (lower agreement between the non-laboratory-based and Framingham (1991) CHD risk scores). Approximately 18% of adults in the DHS population were characterized as ‘high CVD risk’ (10-year CVD death risk >20%) using the non-laboratory-based score.ConclusionsWe found a high level of correlation between a simple, non-laboratory-based CVD risk score and commonly-used laboratory-based risk scores. The burden of CVD mortality risk was high for men and women in South Africa. The policy and clinical implications are that fast, low-cost screening tools can lead to similar risk assessment results compared to time- and resource-intensive approaches. Until setting-specific cohort studies can derive and validate country-specific risk scores, non-laboratory-based CVD risk assessment could be an effective and efficient primary CVD screening approach in South Africa.
Implementation Science | 2011
Kerry Uebel; Lara Fairall; Dingie van Rensburg; Willie Frederick Mollentze; Max Bachmann; Simon Lewin; Merrick Zwarenstein; Christopher J. Colvin; Daniella Georgeu; Pat Mayers; Gill Faris; Carl Lombard; Eric D. Bateman
BackgroundTask shifting and the integration of human immunodeficiency virus (HIV) care into primary care services have been identified as possible strategies for improving access to antiretroviral treatment (ART). This paper describes the development and content of an intervention involving these two strategies, as part of the Streamlining Tasks and Roles to Expand Treatment and Care for HIV (STRETCH) pragmatic randomised controlled trial.Methods: Developing the interventionThe intervention was developed following discussions with senior management, clinicians, and clinic staff. These discussions revealed that the establishment of separate antiretroviral treatment services for HIV had resulted in problems in accessing care due to the large number of patients at ART clinics. The intervention developed therefore combined the shifting from doctors to nurses of prescriptions of antiretrovirals (ARVs) for uncomplicated patients and the stepwise integration of HIV care into primary care services.Results: Components of the interventionThe intervention consisted of regulatory changes, training, and guidelines to support nurse ART prescription, local management teams, an implementation toolkit, and a flexible, phased introduction. Nurse supervisors were equipped to train intervention clinic nurses in ART prescription using outreach education and an integrated primary care guideline. Management teams were set up and a STRETCH coordinator was appointed to oversee the implementation process.DiscussionThree important processes were used in developing and implementing this intervention: active participation of clinic staff and local and provincial management, educational outreach to train nurses in intervention sites, and an external facilitator to support all stages of the intervention rollout.The STRETCH trial is registered with Current Control Trials ISRCTN46836853.
PLOS ONE | 2013
Kerry Uebel; Gina Joubert; Edwin Wouters; Willie Frederick Mollentze; Dingie van Rensburg
Background Integration of human immunodeficiency virus (HIV) care into primary care services is one strategy proposed to achieve universal access to antiretroviral treatment (ART) for HIV-positive patients in high burden countries. There is a need for controlled studies of programmes to integrate HIV care with details of the services being integrated. Methods A semi-quantitative questionnaire was developed in consultation with clinic staff, tested for internal consistency using Cronbachs alpha coefficients and checked for inter-observer reliability. It was used to conduct four assessments of the integration of HIV care into referring primary care clinics (mainstreaming HIV) and into the work of all nurses within ART clinics (internal integration) and the integration of pre-ART and ART care during the Streamlining Tasks and Roles to Expand Treatment and Care for HIV (STRETCH) trial in South Africa. Mean total integration and four component integration scores at intervention and control clinics were compared using one way analysis of variance (ANOVA). Repeated measures ANOVA was used to analyse changes in scores during the trial. Results Cronbachs alpha coefficients for total integration, pre-ART and ART integration and mainstreaming HIV and internal integration scores showed good internal consistency. Mean total integration, mainstreaming HIV and ART integration scores increased significantly at intervention clinics by the third assessment. Mean pre-ART integration scores were almost maximal at the first assessment and showed no further change. There was no change in mean internal integration score. Conclusion The questionnaire developed in this study is a valid tool with potential for monitoring integration of HIV care in other settings. The STRETCH trial interventions resulted in increased integration of HIV care, particularly ART care, by providing HIV care at referring primary care clinics, but had no effect on integrating HIV care into the work of all nurses with the ART clinic.
Journal of Acquired Immune Deficiency Syndromes | 2013
Kerry Uebel; Carl Lombard; Gina Joubert; Lara Fairall; Max Bachmann; Willie Frederick Mollentze; van Rensburg D; Edwin Wouters
Background:Integration of HIV care into primary care is a potential strategy to improve access to antiretroviral therapy (ART) in high-burden countries. This study was conducted to determine the effect of integration of HIV care on the survival of patients needing ART. Methods:A questionnaire was used to measure the integration of HIV care into primary care during a randomized controlled trial of task shifting and decentralization of HIV care in South Africa. Cox proportional hazard ratios (HRs) were estimated for the effect of 5 different integration scores (total, pre-ART, ART, mainstreaming HIV, and internal integration) on the survival of patients with CD4 count ⩽350 cells per microliter and not yet on ART. Results:A total of 9252 patients were followed up for 12–18 months. Cox proportional HRs adjusted for patient and clinic characteristics showed decreased risk of mortality in clinics with high scores for total integration [HR, 0.97; 95% confidence interval (CI), 0.95 to 0.98; P < 0.001], ART integration (HR, 0.94; 95% CI, 0.90 to 0.99; P = 0.013), and internal integration (HR, 0.97; 95% CI, 0.95 to 1.00; P = 0.041). Analysis of the effect of component scores adjusted for patient characteristics only showed decreased risk of mortality in clinics with high scores for total integration (HR, 0.97; 95% CI, 0.94 to 1.00; P = 0.032), pre-ART integration (HR, 0.92; 95% CI, 0.85 to 0.99; P = 0.027), ART integration (HR, 0.95; 95% CI, 0.93 to 0.98; P = 0.001), and mainstreaming HIV (HR, 0.90; 95% CI, 0.83 to 0.97; P = 0.007). Conclusion:In a context of task shifting and decentralization of care, integration of HIV care into primary care is associated with improved survival of HIV-positive patients needing ART.
South African Medical Journal | 2010
Kerry Uebel; Venessa Timmerman; Suzanne M Ingle; Dingie van Rensburg; Willie Frederick Mollentze
OBJECTIVE To study the progress and challenges with regard to universal antiretroviral (ARV) access in Free State Province, South Africa. METHODS Data from the first 4 years of the public sector ARV roll-out and selected health system indicators were used. Data were collected from the public sector ARV database in Free State Province for new patients on ARVs, average waiting times and median CD4 counts at the start of treatment. Information on staff training, vacancy rates and funding allocations for the ARV roll-out was obtained from official government reports. Projections were made of expected new ARV enrolments for 2008 and 2009 and compared with goals set by the National Strategic Plan (NSP) to achieve universal access to ARVs by 2011. RESULTS New ARV enrolments increased annually to 25% of the estimated need by the end of 2007. Average waiting times to enrolment decreased from 5.82 months to 3.24 months. Median CD4 counts at enrolment increased from 89 to 124 cells/mm3. There is a staff vacancy rate of 38% in the ARV programme and an inadequate increase in budget allocations. CONCLUSION The current vertical model of ARV therapy delivery is unlikely to raise the number of new enrolments sufficiently to achieve the goals of universal access by 2011 as envisaged by the NSP. The Free State is implementing a project (STRETCH trial) to broaden the ARV roll-out in an attempt to increase access to ARVs.
South African Medical Journal | 2006
Willie Frederick Mollentze
The World Health Organization (WHO) defines obesity as a disease in which excess body fat has accumulated to such an extent that health may be adversely affected.
South African Family Practice | 2012
Willie Frederick Mollentze
Globally, type 2 diabetes remains the most common type of diabetes, and its prevalence is rising, unabatedly driven by physical inactivity and the emerging epidemic of obesity. 1 The risk of developing type 2 diabetes is especially increased in rural girls, of whom up to 25% are already overweight or obese in late adolescence. 2
International Journal of Obesity | 2018
Kenneth Ekoru; Georgina Murphy; Elizabeth H. Young; H Delisle; C S Jerome; Felix K. Assah; B Longo–Mbenza; J P D Nzambi; J B K On'Kin; F Buntix; M C Muyer; D L Christensen; C S Wesseh; A Sabir; C Okafor; I D Gezawa; F Puepet; O Enang; T Raimi; E Ohwovoriole; O O Oladapo; Pascal Bovet; Willie Frederick Mollentze; Nigel Unwin; W K Gray; R Walker; K Agoudavi; S Siziya; J Chifamba; Marina Njelekela
Background:Waist circumference (WC) thresholds derived from western populations continue to be used in sub-Saharan Africa (SSA) despite increasing evidence of ethnic variation in the association between adiposity and cardiometabolic disease and availability of data from African populations. We aimed to derive a SSA-specific optimal WC cut-point for identifying individuals at increased cardiometabolic risk.Methods:We used individual level cross-sectional data on 24 181 participants aged ⩾15 years from 17 studies conducted between 1990 and 2014 in eight countries in SSA. Receiver operating characteristic curves were used to derive optimal WC cut-points for detecting the presence of at least two components of metabolic syndrome (MS), excluding WC.Results:The optimal WC cut-point was 81.2 cm (95% CI 78.5–83.8 cm) and 81.0 cm (95% CI 79.2–82.8 cm) for men and women, respectively, with comparable accuracy in men and women. Sensitivity was higher in women (64%, 95% CI 63–65) than in men (53%, 95% CI 51–55), and increased with the prevalence of obesity. Having WC above the derived cut-point was associated with a twofold probability of having at least two components of MS (age-adjusted odds ratio 2.6, 95% CI 2.4–2.9, for men and 2.2, 95% CI 2.0–2.3, for women).Conclusion:The optimal WC cut-point for identifying men at increased cardiometabolic risk is lower (⩾81.2 cm) than current guidelines (⩾94.0 cm) recommend, and similar to that in women in SSA. Prospective studies are needed to confirm these cut-points based on cardiometabolic outcomes.
South African Family Practice | 2018
Mt Makwero; Willie Frederick Mollentze; Gina Joubert; Wilhelm Johannes Steinberg
Background: Patients attending outpatient departments for follow-up of diabetes mellitus (DM) may seem content about the control of their disease. However, complications resulting from DM may present before diagnosis and treatment initiation or continue to develop while on treatment. Aim: This study aimed to report on the prevalence of DM complications in patients with DM at Maluti Adventist Hospital, Lesotho. Methods: A cross-sectional study was conducted in 150 DM patients recruited from Maluti Adventist Hospital’s newly formed clinic between May and June 2009. Demographic information was obtained through a structured interview. Patients underwent physical and eye examinations to obtain an anthropometric profile and identify DM complications. Laboratory and ECG investigations were done to establish level of glycaemic control and identify other complications. Results: Patients were female (80.7%) with a mean age of 58.2 years (standard deviation 13.2). Almost all patients had type 2 DM (94.7%) and 60.1% had been diagnosed during the preceding five years. The most common co-morbidity was hypertension (85.3%) and 49.7% of patients were obese (mean body mass index 30.4 kg/m2). Patients had poor short-term (46.2%) and long-term (57.5%) glycaemic control. Nearly half (43.3%) of the patients had evidence of peripheral neuropathy. Almost 60% of the patients had a blood pressure of > 130/80 mmHg. Of the 128 patients seen by the ophthalmologist, 29.9% had evidence of cataracts in both eyes. Funduscopic abnormalities were found in 32.8% of the patients. Patients with complications or poor glycaemic control had been diagnosed for a significantly longer time. Conclusion: Patients showed evidence of DM complications at the time of study. Coupled with significant co-morbidities and high body mass index, the risk of morbidity and mortality is high. A comprehensive approach is needed in managing these patients, if meaningful reductions in morbidity and mortality are to be achieved.